Endocrinology & Diabetes ResearchISSN: 2470-7570

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Comparison of Lipid Profile in Diabetic Patients taking Oral Hypoglycemic Drugs Versus Insulin Therapy

Background: Diabetes mellitus is the most prevalent disease all around the world. Medication can be prescribed as insulin and oral anti-glycemic. There is also significant impact of diabetic therapy on lipid profile of diabetic patients. Objective: To compare lipid profile of diabetic patients taking oral hypoglycemic drugs versus insulin therapy.

Study design: Quasi experimental study.

Materials and Methods: 70 newly diagnosed cases of diabetes, were recruited and divided in 2 groups. Patients who were prescribed insulin were assigned as group A while patient who were prescribed oral anti-glycemic were assigned as group B. The patients were followed for 3 months for serum lipid profile and findings of the lab were noted on proforma. The collected data was analyzed by SPSS-23. Both groups were compared by using student t test at the level of significance ≤ 0.05.

Results: In this study, the mean age of patients was 46.77 years ± 14.80 years in patients taking insulin while 46.89 years ± 14.57 years in oral anti-glycemic group. In patients taking insulin, there were 20 (57.1%) males and 15 (42.9%) females. In oral anti-glycemic group, there were 20 (57.1%) males and 15 (42.9%) females. After 3 months of anti-glycemic course, mean total cholesterol level was 211.74 mg/dl ± 27.59 mg/dl versus 292.97 mg/dl ± 49.72 mg/dl, mean triglycerides level was 216.89 mg/dl ± 50.29 mg/dl versus 262.69 ± 72.33 mg/dl, mean LDL level was 163.34 ± 22.47 mg/dl versus 196.00 ± 24.70 mg/dl and mean HDL level was 48.91 mg/dl ± 9.27 mg/dl versus 46.31 ± 5.14 mg/dl in patients taking insulin therapy versus oral anti-glycemic respectively. Conclusion: We observed through this trial that the lipid profile of patient taking insulin therapy is more under controlled than patients taking oral anti-glycemic medication.

Conclusion: We observed through this trial that the lipid profile of patient taking insulin therapy is more under controlled than patients taking oral anti-glycemic medication.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

Associations

GET THE APP